Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential.

Valorani MG, Germani A, Otto WR, Harper L, Biddle A, Khoo CP, Lin WR, Hawa MI, Tropel P, Patrizi MP, Pozzilli P, Alison MR.

Cell Tissue Res. 2010 Jul;341(1):111-20. doi: 10.1007/s00441-010-0982-8. Epub 2010 May 23.

PMID:
20496083
3.

Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials.

Valorani MG, Montelatici E, Germani A, Biddle A, D'Alessandro D, Strollo R, Patrizi MP, Lazzari L, Nye E, Otto WR, Pozzilli P, Alison MR.

Cell Prolif. 2012 Jun;45(3):225-38. doi: 10.1111/j.1365-2184.2012.00817.x.

PMID:
22507457
4.

DNER modulates adipogenesis of human adipose tissue-derived mesenchymal stem cells via regulation of cell proliferation.

Park JR, Jung JW, Seo MS, Kang SK, Lee YS, Kang KS.

Cell Prolif. 2010 Feb;43(1):19-28. doi: 10.1111/j.1365-2184.2009.00650.x.

PMID:
20070733
5.

Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.

Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K.

J Bone Miner Res. 2005 Sep;20(9):1647-58. Epub 2005 May 23.

6.

Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells.

Hung SP, Ho JH, Shih YR, Lo T, Lee OK.

J Orthop Res. 2012 Feb;30(2):260-6. doi: 10.1002/jor.21517. Epub 2011 Aug 1.

7.

Effect of cell density on adipogenic differentiation of mesenchymal stem cells.

Lu H, Guo L, Wozniak MJ, Kawazoe N, Tateishi T, Zhang X, Chen G.

Biochem Biophys Res Commun. 2009 Apr 10;381(3):322-7.

PMID:
19309772
8.

Effect of ceramide on mesenchymal stem cell differentiation toward adipocytes.

Xu F, Yang CC, Gomillion C, Burg KJ.

Appl Biochem Biotechnol. 2010 Jan;160(1):197-212. doi: 10.1007/s12010-008-8505-8. Epub 2009 Jan 23.

PMID:
19165630
9.
10.

Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies.

Komoda H, Okura H, Lee CM, Sougawa N, Iwayama T, Hashikawa T, Saga A, Yamamoto-Kakuta A, Ichinose A, Murakami S, Sawa Y, Matsuyama A.

Tissue Eng Part A. 2010 Apr;16(4):1143-55. doi: 10.1089/ten.TEA.2009.0386.

PMID:
19863253
11.

Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia.

Dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM.

J Cell Physiol. 2010 Apr;223(1):27-35. doi: 10.1002/jcp.21987.

PMID:
20020504
12.

Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions.

Ren H, Cao Y, Zhao Q, Li J, Zhou C, Liao L, Jia M, Zhao Q, Cai H, Han ZC, Yang R, Chen G, Zhao RC.

Biochem Biophys Res Commun. 2006 Aug 18;347(1):12-21. Epub 2006 Jun 6.

PMID:
16814746
13.

Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.

Frith JE, Thomson B, Genever PG.

Tissue Eng Part C Methods. 2010 Aug;16(4):735-49. doi: 10.1089/ten.TEC.2009.0432.

PMID:
19811095
14.

Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.

Hoffmann J, Glassford AJ, Doyle TC, Robbins RC, Schrepfer S, Pelletier MP.

Thorac Cardiovasc Surg. 2010 Apr;58(3):136-42. doi: 10.1055/s-0029-1240758.

PMID:
20379963
15.

Isolation and characterization of canine adipose-derived mesenchymal stem cells.

Neupane M, Chang CC, Kiupel M, Yuzbasiyan-Gurkan V.

Tissue Eng Part A. 2008 Jun;14(6):1007-15. doi: 10.1089/tea.2007.0207.

PMID:
19230125
16.

Adipogenic differentiation of mesenchymal stem cells on micropatterned polyelectrolyte surfaces.

Kawazoe N, Guo L, Wozniak MJ, Imaizumi Y, Tateishi T, Zhang X, Chen G.

J Nanosci Nanotechnol. 2009 Jan;9(1):230-9.

PMID:
19441301
17.

Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs.

Grayson WL, Zhao F, Izadpanah R, Bunnell B, Ma T.

J Cell Physiol. 2006 May;207(2):331-9.

PMID:
16331674
18.

Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy.

Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro AR, Shapiro IM.

Spine (Phila Pa 1976). 2004 Dec 1;29(23):2627-32.

PMID:
15564911
19.

Mesenchymal stem cells from CD34(-) human umbilical cord blood.

Lu X, Alshemali S, de Wynter EA, Dickinson AM.

Transfus Med. 2010 Jun;20(3):178-84. doi: 10.1111/j.1365-3148.2009.00981.x. Epub 2009 Nov 23.

PMID:
19948008
20.

Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.

Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T.

J Cell Physiol. 2005 Nov;205(2):194-201.

PMID:
15880640

Supplemental Content

Support Center